Cargando…
Strategy for Identification of Phosphorylation Levels of Low Abundance Proteins in Vivo for Which Antibodies Are not Available
Protein function is mainly modulated by dynamic reversible or irreversible post-translational modifications. Among them, the identification of protein phosphorylation sites and changes in phosphorylation levels in vivo are of considerable interest for a better understanding of the protein function....
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753118/ https://www.ncbi.nlm.nih.gov/pubmed/29367546 http://dx.doi.org/10.3390/jcdd4040017 |
_version_ | 1783290209769619456 |
---|---|
author | Hayashi, Kozo Yamashita, Ryo Takami, Ritsuko Matsui, Toshikatsu Gotou, Masamitsu Nishimoto, Tomoyuki Kobayashi, Hiroyuki |
author_facet | Hayashi, Kozo Yamashita, Ryo Takami, Ritsuko Matsui, Toshikatsu Gotou, Masamitsu Nishimoto, Tomoyuki Kobayashi, Hiroyuki |
author_sort | Hayashi, Kozo |
collection | PubMed |
description | Protein function is mainly modulated by dynamic reversible or irreversible post-translational modifications. Among them, the identification of protein phosphorylation sites and changes in phosphorylation levels in vivo are of considerable interest for a better understanding of the protein function. Thus, effective strategies for the quantitative determination of phosphorylation degrees for low abundant proteins, for which antibodies are not available, are required in order to evaluate the functional regulation of proteins attributed to phosphorylation. In this study, we used the heart β1-adrenergic receptor (Adrb1) as a model protein and developed FLAG-Adrb1 knock-in mice, in which the FLAG tag was inserted at the N-terminus of Adrb1. The phosphorylation sites and levels of Adrb1 in the heart were elucidated by immuno-affinity purification followed by quantitative mass spectrometry analysis using ion intensity ratio of the phosphorylated peptide versus corresponding unphosphorylated peptide. The phosphorylation levels at Ser274 and Ser462 of Adrb1 were approximately 0.25 and 0.0023. This effective strategy should be useful for not only analyzing site-specific phosphorylation levels of target proteins, but also quantifying the expression levels of proteins of interest when appropriate antibodies are not available. |
format | Online Article Text |
id | pubmed-5753118 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-57531182018-01-19 Strategy for Identification of Phosphorylation Levels of Low Abundance Proteins in Vivo for Which Antibodies Are not Available Hayashi, Kozo Yamashita, Ryo Takami, Ritsuko Matsui, Toshikatsu Gotou, Masamitsu Nishimoto, Tomoyuki Kobayashi, Hiroyuki J Cardiovasc Dev Dis Article Protein function is mainly modulated by dynamic reversible or irreversible post-translational modifications. Among them, the identification of protein phosphorylation sites and changes in phosphorylation levels in vivo are of considerable interest for a better understanding of the protein function. Thus, effective strategies for the quantitative determination of phosphorylation degrees for low abundant proteins, for which antibodies are not available, are required in order to evaluate the functional regulation of proteins attributed to phosphorylation. In this study, we used the heart β1-adrenergic receptor (Adrb1) as a model protein and developed FLAG-Adrb1 knock-in mice, in which the FLAG tag was inserted at the N-terminus of Adrb1. The phosphorylation sites and levels of Adrb1 in the heart were elucidated by immuno-affinity purification followed by quantitative mass spectrometry analysis using ion intensity ratio of the phosphorylated peptide versus corresponding unphosphorylated peptide. The phosphorylation levels at Ser274 and Ser462 of Adrb1 were approximately 0.25 and 0.0023. This effective strategy should be useful for not only analyzing site-specific phosphorylation levels of target proteins, but also quantifying the expression levels of proteins of interest when appropriate antibodies are not available. MDPI 2017-10-08 /pmc/articles/PMC5753118/ /pubmed/29367546 http://dx.doi.org/10.3390/jcdd4040017 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Hayashi, Kozo Yamashita, Ryo Takami, Ritsuko Matsui, Toshikatsu Gotou, Masamitsu Nishimoto, Tomoyuki Kobayashi, Hiroyuki Strategy for Identification of Phosphorylation Levels of Low Abundance Proteins in Vivo for Which Antibodies Are not Available |
title | Strategy for Identification of Phosphorylation Levels of Low Abundance Proteins in Vivo for Which Antibodies Are not Available |
title_full | Strategy for Identification of Phosphorylation Levels of Low Abundance Proteins in Vivo for Which Antibodies Are not Available |
title_fullStr | Strategy for Identification of Phosphorylation Levels of Low Abundance Proteins in Vivo for Which Antibodies Are not Available |
title_full_unstemmed | Strategy for Identification of Phosphorylation Levels of Low Abundance Proteins in Vivo for Which Antibodies Are not Available |
title_short | Strategy for Identification of Phosphorylation Levels of Low Abundance Proteins in Vivo for Which Antibodies Are not Available |
title_sort | strategy for identification of phosphorylation levels of low abundance proteins in vivo for which antibodies are not available |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753118/ https://www.ncbi.nlm.nih.gov/pubmed/29367546 http://dx.doi.org/10.3390/jcdd4040017 |
work_keys_str_mv | AT hayashikozo strategyforidentificationofphosphorylationlevelsoflowabundanceproteinsinvivoforwhichantibodiesarenotavailable AT yamashitaryo strategyforidentificationofphosphorylationlevelsoflowabundanceproteinsinvivoforwhichantibodiesarenotavailable AT takamiritsuko strategyforidentificationofphosphorylationlevelsoflowabundanceproteinsinvivoforwhichantibodiesarenotavailable AT matsuitoshikatsu strategyforidentificationofphosphorylationlevelsoflowabundanceproteinsinvivoforwhichantibodiesarenotavailable AT gotoumasamitsu strategyforidentificationofphosphorylationlevelsoflowabundanceproteinsinvivoforwhichantibodiesarenotavailable AT nishimototomoyuki strategyforidentificationofphosphorylationlevelsoflowabundanceproteinsinvivoforwhichantibodiesarenotavailable AT kobayashihiroyuki strategyforidentificationofphosphorylationlevelsoflowabundanceproteinsinvivoforwhichantibodiesarenotavailable |